Sign In
Buy MKGAF
$149.28
-7.84 (-4.99%)
At Close: Jun 22, 2026
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case
02:22pm, Thursday, 04'th Dec 2025
The Munich Regional Court ruled there was imminent infringement for Merck & Co.'s Keytruda SC in Germany related to Halozyme's MDASE patents in Europe, the San Diego company said.
Merck KGaA (MKKGY) Q3 2025 Earnings Call Transcript
04:41pm, Thursday, 13'th Nov 2025
Merck KGaA (OTCPK:MKKGY) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Florian Schraeder - Head of Investor Relations Belén Garijo López - Chair of Executive Board & CEO H
MusclePharm (OTCMKTS:MSLP) and Merck KGaA (OTCMKTS:MKGAF) Head-To-Head Analysis
03:58am, Thursday, 30'th Oct 2025
Volatility and Risk MusclePharm has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500. Comparatively, Merck KGaA has a beta of 0.96, suggesting that its share pri
Merck KGaA: An AI-Resistant Pharma Play
09:39am, Friday, 24'th Oct 2025
Merck KGaA (MKGAF) is deeply undervalued, offering a compelling entry point with strong fundamentals and resilience to AI disruption. MKGAF's diversified segments—life science, healthcare (biologics
Histogen (NASDAQ:HSTO) vs. Merck KGaA (OTCMKTS:MKGAF) Head-To-Head Contrast
02:42am, Friday, 24'th Oct 2025
Earnings and Valuation This table compares Histogen and Merck KGaA"s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Histo
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
04:57pm, Thursday, 16'th Oct 2025
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for in vitro fertilization, with the move com
Trump announces efforts to expand access to IVF drugs
04:55pm, Thursday, 16'th Oct 2025
President Donald Trump announced two new efforts to expand availability of in vitro fertilization, the first concrete step from the Trump administration on the expensive, decades-old procedure. It inc
Trump Announces Deal With Germany's Merck on IVF Costs
04:32pm, Thursday, 16'th Oct 2025
President Donald Trump announces a deal with Germany's Merck KGaA to cut the price of some of its fertility medicines in exchange for relief from threatened tariffs. He speaks during a a press con
Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets
02:00am, Thursday, 16'th Oct 2025
The company confirmed its 2025 guidance and is targeting annual organic sales growth in the mid-single-digit percentage range and an expansion in profitability over the medium term.
Germany's Merck tweaks mid-term healthcare unit guidance
01:04am, Thursday, 16'th Oct 2025
German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday.
Chinese police investigating app fraud case, says German drugmaker Merck KGaA
07:43am, Tuesday, 23'rd Sep 2025
Police in China are investigating an app fraud case, said German healthcare firm Merck KGaA , amid growing concerns over entities claiming affiliation with major corporations.
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
08:00pm, Wednesday, 03'rd Sep 2025
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drug
mRNA Biotechs - Long-Term Value Risks Abound
06:20am, Thursday, 28'th Aug 2025
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c
Merck KGaA (MKGAF) Q2 2025 Earnings Call Transcript
10:44pm, Thursday, 07'th Aug 2025
Merck KGaA (OTCPK:MKGAF) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Belen Garijo Lopez - Chair of Executive Board & CEO Danny Bar-Zohar - Member of the Executive B
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has closed the acquisition of SpringWorks Therapeutics, Inc., for
